SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 201,459.10 |
| Enterprise Value ($M) | 219,678.10 |
| Book Value ($M) | 44,126.00 |
| Book Value / Share | 22.34 |
| Price / Book | 4.57 |
| NCAV ($M) | -28,416.00 |
| NCAV / Share | -14.39 |
| Price / NCAV | -7.09 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.16 |
| Return on Assets (ROA) | 0.12 |
| Return on Equity (ROE) | 0.26 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.84 |
| Current Ratio | 1.04 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 29,704.00 |
| Assets | 102,246.00 |
| Liabilities | 58,120.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 51,722.00 |
| Operating Income | 16,320.00 |
| Net Income | 11,941.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 17,619.00 |
| Cash from Investing | -7,513.00 |
| Cash from Financing | -11,742.00 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| NTBLQ – Notable Labs, Ltd. | NTRR – Neutra Corp. |
| NUNZ – Nunzia Pharmaceutical Company | NVYTF – Novacyt S.A. |
| NWBO – Northwest Biotherapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io